Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
Authors: Bookman, Michael A | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | May 22, 2024 | PubMed abstract
